Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Endocannabinoid system: potential novel targets for treatment of schizophrenia.

Saito A, Ballinger MD, Pletnikov MV, Wong DF, Kamiya A.

Neurobiol Dis. 2013 May;53:10-7. doi: 10.1016/j.nbd.2012.11.020. Epub 2012 Dec 7. Review.

2.

ACSL6 is associated with the number of cigarettes smoked and its expression is altered by chronic nicotine exposure.

Chen J, Brunzell DH, Jackson K, van der Vaart A, Ma JZ, Payne TJ, Sherva R, Farrer LA, Gejman P, Levinson DF, Holmans P, Aggen SH, Damaj I, Kuo PH, Webb BT, Anton R, Kranzler HR, Gelernter J, Li MD, Kendler KS, Chen X.

PLoS One. 2011;6(12):e28790. doi: 10.1371/journal.pone.0028790. Epub 2011 Dec 20. Erratum in: PLoS One. 2012;7(8). doi: 10.1371/annotation/071abcbd-6f0c-4c4b-9507-dae42450457e.

3.

Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidence.

Hillard CJ, Weinlander KM, Stuhr KL.

Neuroscience. 2012 Mar 1;204:207-29. doi: 10.1016/j.neuroscience.2011.11.020. Epub 2011 Nov 17. Review.

4.

Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects.

Marco EM, García-Gutiérrez MS, Bermúdez-Silva FJ, Moreira FA, Guimarães F, Manzanares J, Viveros MP.

Front Behav Neurosci. 2011 Oct 5;5:63. doi: 10.3389/fnbeh.2011.00063. eCollection 2011.

5.

Cannabis and schizophrenia spectrum disorders: a review of clinical studies.

Rodrigo C, Rajapakse S.

Indian J Psychol Med. 2009 Jul;31(2):62-70. doi: 10.4103/0253-7176.63575.

6.

Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia.

Ho BC, Wassink TH, Ziebell S, Andreasen NC.

Schizophr Res. 2011 May;128(1-3):66-75. doi: 10.1016/j.schres.2011.02.021. Epub 2011 Mar 21.

7.

A retrospective analysis of cannabis use in a cohort of mentally ill patients in Sri Lanka and its implications on policy development.

Rodrigo C, Welgama S, Gunawardana A, Maithripala C, Jayananda G, Rajapakse S.

Subst Abuse Treat Prev Policy. 2010 Jul 8;5:16. doi: 10.1186/1747-597X-5-16.

8.

Association of polymorphisms of the cannabinoid receptor (CNR1) and fatty acid amide hydrolase (FAAH) genes with heroin addiction: impact of long repeats of CNR1.

Proudnikov D, Kroslak T, Sipe JC, Randesi M, Li D, Hamon S, Ho A, Ott J, Kreek MJ.

Pharmacogenomics J. 2010 Jun;10(3):232-42. doi: 10.1038/tpj.2009.59. Epub 2009 Dec 15.

9.

Cannabis and psychosis/schizophrenia: human studies.

D'Souza DC, Sewell RA, Ranganathan M.

Eur Arch Psychiatry Clin Neurosci. 2009 Oct;259(7):413-31. doi: 10.1007/s00406-009-0024-2. Epub 2009 Jul 16. Review.

10.

Cannabinoid receptor 1 gene association with nicotine dependence.

Chen X, Williamson VS, An SS, Hettema JM, Aggen SH, Neale MC, Kendler KS.

Arch Gen Psychiatry. 2008 Jul;65(7):816-24. doi: 10.1001/archpsyc.65.7.816.

11.

Association of the cannabinoid receptor gene (CNR1) with ADHD and post-traumatic stress disorder.

Lu AT, Ogdie MN, Järvelin MR, Moilanen IK, Loo SK, McCracken JT, McGough JJ, Yang MH, Peltonen L, Nelson SF, Cantor RM, Smalley SL.

Am J Med Genet B Neuropsychiatr Genet. 2008 Dec 5;147B(8):1488-94. doi: 10.1002/ajmg.b.30693.

12.

Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia?

Solowij N, Michie PT.

J Psychiatry Neurosci. 2007 Jan;32(1):30-52. Review.

Supplemental Content

Support Center